Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, Hager K, Andreasen N, Scarpini E, Liu-Seifert H, Case M, Dean RA, Hake A, Sundell K, Poole Hoffmann V, Carlson C, Khanna R, Mintun M, DeMattos R, Selzler KJ, Siemers E. Honig LS, et al. Among authors: hager k. N Engl J Med. 2018 Jan 25;378(4):321-330. doi: 10.1056/NEJMoa1705971. N Engl J Med. 2018. PMID: 29365294 Clinical Trial.
Plasma fibrinogen - are there age-dependent changes?
Hager K, Seefried G, Felicetti M, Platt D. Hager K, et al. Arch Gerontol Geriatr. 1994;19 Suppl 1:99-106. doi: 10.1016/s0167-4943(05)80054-8. Arch Gerontol Geriatr. 1994. PMID: 18649849
Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease.
Selle H, Lamerz J, Buerger K, Dessauer A, Hager K, Hampel H, Karl J, Kellmann M, Lannfelt L, Louhija J, Riepe M, Rollinger W, Tumani H, Schrader M, Zucht HD. Selle H, et al. Among authors: hager k. Comb Chem High Throughput Screen. 2005 Dec;8(8):801-6. doi: 10.2174/138620705774962391. Comb Chem High Throughput Screen. 2005. PMID: 16464167
183 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page